Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
18 Oct 2024
See more Multinational company Covestro invests €51 million to decarbonize its Tarragona plantMultinational company Covestro invests €51 million to decarbonize its Tarragona plant
-
15 Oct 2024
See more LCI Education invests €33 million in a new European hub in BarcelonaLCI Education invests €33 million in a new European hub in Barcelona
-
14 Oct 2024
See more Chinese AI company Coovally to set up its global headquarters in BarcelonaChinese AI company Coovally to set up its global headquarters in Barcelona
-
11 Oct 2024
See more Applus+ IDIADA opens an advanced Battery Safety laboratory in CataloniaApplus+ IDIADA opens an advanced Battery Safety laboratory in Catalonia
